Krystal Biotech Free Cash Flow (Quarterly) Analysis

Krystal Biotech Inc (KRYS)

154.52 -4.22 (-2.66%) USD | NASDAQ | May 10, 16:00

154.52 0.00 (0.00%) After-Hours: 19:34

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	14.63M
December 31, 2023	-9.079M
September 30, 2023	-23.01M
June 30, 2023	-36.98M
March 31, 2023	-31.54M
December 31, 2022	-27.55M
September 30, 2022	-33.74M
June 30, 2022	-59.57M
March 31, 2022	-32.68M
December 31, 2021	-61.78M
September 30, 2021	-28.25M
June 30, 2021	-14.12M
March 31, 2021	-12.13M
December 31, 2020	-15.23M
September 30, 2020	-10.96M

Date	Value
June 30, 2020	-7.00M
March 31, 2020	-7.735M
December 31, 2019	-9.279M
September 30, 2019	-5.441M
June 30, 2019	-5.447M
March 31, 2019	-4.922M
December 31, 2018	-4.822M
September 30, 2018	-2.772M
June 30, 2018	-1.716M
March 31, 2018	-2.369M
December 31, 2017	-2.286M
September 30, 2017	-1.11M
June 30, 2017	-0.44M
March 31, 2017	-0.264M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-61.78M

Minimum

Dec 2021

14.63M

Maximum

Mar 2024

-20.84M

Average

-14.67M

Median

Free Cash Flow (Quarterly) Benchmarks